Search Results 191-200 of 1923 for ⚕보급형 ARP프로토콜 노후투자 확장성이좋다⚕
The goal of the study is to compare and evaluate safety and efficacy of tesevatinib 50mg versus placebo in patients with ADPKD. Participation eligibility.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Early identification of cognitive decline in neurodegenerative disease using digital assessment. Dr. Boots uses a web-based cognitive testing platform — Mayo ...
Sponsor Protocol Number: CC-5013-CLL-002. About this study. The purpose of this study is to determine if lenalidomide (Revlimid®) is safe and effective as a ...
Sponsor Protocol Number: 13-006606. About this study. The aim of this study is to evaluate the relation of the acute pacing threshold (volts at 'x' pulse ...
Sponsor Protocol Number: M16-312. About this study. This is a multicenter, open-label, Phase 1 study in participants with colorectal cancer (CRC), and ...
Search the more than 400 medical, surgical, health sciences, and biomedical research training programs at Mayo Clinic College of ...
Sponsor Protocol Number: 19-004937. About this study. The purposes of this study are to validate noninvasive hemoglobin monitoring in postoperative orthopedic ...
Sponsor Protocol Number: 09-001079. About this study. The purpose of this study is to learn more about incidence of infection complications in recipients of ...
Participants to be enrolled in this study will have been scheduled to have laparoscopic genitourinary surgery and EPAD monitoring as part of their clinical care ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.